Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2012

Study Completion Date

October 31, 2015

Conditions
Parkinson's Disease
Interventions
DEVICE

B-STN DBS

Deep brain stimulation (DBS) of both the right and left sub-thalamic nucleus (STN) is an FDA approved treatment for advanced PD. In mid- and advanced stage Parkinson's disease, using DBS in this area of the brain lessens symptoms and allows patients to take less drug to control the disease. Dosage and frequency are not applicable to the DBS. Once the DBS is placed, unless deemed necessary, it will not be removed.

DRUG

Optimal drug therapy

The drugs used on this study are not investigational. They are drugs for Parkinson's disease that are standard of care. The drug form, dosage, frequency and duration will vary. Examples of drugs used include carbidopa/levodopa, pramipexole, ropinirole, and selegiline.

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT00282152 - Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD) | Biotech Hunter | Biotech Hunter